Helong Xiao

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway Activation.

NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway Activation.

Journal: Cardiovascular drugs and therapy

Published: December 11, 2025

A cross-sectional study of the quality and reliability of renal cell carcinoma-related short videos on Bilibili and TikTok.

A cross-sectional study of the quality and reliability of renal cell carcinoma-related short videos on Bilibili and TikTok.

Journal: Digital health

Published: September 19, 2025

NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells.

NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells.

Journal: Translational andrology and urology

Published: April 29, 2024

The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis.

The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis.

Journal: Neurourology and urodynamics

Published: September 26, 2023

Malignant glomus tumor of prostate: A case report.

Malignant glomus tumor of prostate: A case report.

Journal: Frontiers in oncology

Published: December 11, 2022

Influences of Different Operative Methods on the Recurrence Rate of Non-Muscle-Invasive Bladder Cancer.

Influences of Different Operative Methods on the Recurrence Rate of Non-Muscle-Invasive Bladder Cancer.

Journal: Urology journal

Published: October 01, 2020

Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway.

Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway.

Journal: Drug development research

Published: August 26, 2020

Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate Cancer.

Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate Cancer.

Journal: BioMed research international

Published: March 16, 2020

Induction of entosis in prostate cancer cells by nintedanib and its therapeutic implications.

Induction of entosis in prostate cancer cells by nintedanib and its therapeutic implications.

Journal: Oncology letters

Published: December 19, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026